Myostatin expression, lymphocyte population, and potential cytokine production correlate with predisposition to high-fat diet induced obesity in mice

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-13

  Lyons, Jeri Anne ^a   Haring, Jodie S ^b   Biga, Peggy R ^b  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; MYOSTATIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL COMPOSITION; CELL METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; GROWTH; INFLAMMATION; LIPID DIET; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SPLEEN CELL; SWISS WEBSTER MOUSE; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; C57BL MOUSE; FAT INTAKE; FEMALE; GENE EXPRESSION; GENETIC SCREENING; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE COUNT; MALE; SKELETAL MUSCLE; SPLEEN; T LYMPHOCYTE;

MUS;

ANIMALS; CYTOKINES; DIETARY FATS; FEMALE; GENE EXPRESSION; GENETIC TESTING; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOSTATIN; OBESITY; ORGAN SPECIFICITY; SPLEEN; T-LYMPHOCYTES;

EID: 77958490950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012928     Document Type: Article

References (54)

1. Unger RH (2002) Lipotoxic diseases. Annu Rev Med 53: 319-336.
2. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404(6779): 787-790.
3. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341(4): 240-246.
4. Baron AD, Brechtel G, Wallace P, Edelman SV (1988) Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 255(6 Pt 1): E769-774.
5. Dagenais GR, Tancredi RG, Zierler KL (1976) Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest 58(2): 421-431.
6. Zhao B, Wall RJ, Yang J (2005) Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun 337(1): 248-255.
7. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, et al. (1999) Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180(1): 1-9.
8. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, et al. (2001) Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60(3): 351-361.
9. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387(6628): 83-90.
10. McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109(5): 595-601.
11. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, et al. (2004) Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 270(1): 19-30.
12. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, et al. (2002) The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277(43): 40735-40741.
13. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, et al. (2003) Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285(4): E876-888.
14. Guzik TJ, Mangalat D, Korbut R (2006) Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol 57(4): 505-528.
15. White LJ, Ferguson MA, McCoy SC, Kim HW, Castellano V (2006) Cardiovascular/ non-insulin-dependent diabetes mellitus risk factors and intramyocellular lipid in healthy subjects: a sex comparison. Metabolism 55(1): 128-134.
16. Gottschlich MM, Mayes T, Khoury JC, Warden GD (1993) Significance of obesity on nutritional, immunologic, hormonal, and clinical outcome parameters in burns. J Am Diet Assoc 93(11): 1261-1268.
17. Krishnan EC, Trost L, Aarons S, Jewell WR (1982) Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res 33(2): 89-97.
18. Smith AG, Sheridan PA, Harp JB, Beck MA (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 137(5): 1236-1243.
19. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, et al. (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44(5): 645-651.
20. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Dietinduced type II diabetes in C57BL/6J mice. Diabetes 37(9): 1163-1167.
21. West DB, Boozer CN, Moody DL, Atkinson RL (1992) Dietary obesity in nine inbred mouse strains. Am J Physiol 262(6 Pt 2): R1025-1032.
22. Trickett A, Kwan YL (2003) T cell stimulation and expansion using anti-CD3/ CD28 beads. J Immunol Methods 275(1-2): 251-255.
23. Pfaffl M (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45.
24. Lewis SR, Dym C, Chai C, Singh A, Kest B, et al. (2007) Genetic variance contributes to ingestive processes: a survey of eleven inbred mouse strains for fat (Intralipid) intake. Physiol Behav 90(1): 82-94.
25. Paigen B (1995) Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 62(2): 458S-462S.
26. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, et al. (2009) Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4(3): e4937.
27. Hamrick MW, Pennington C, Webb CN, Isales CM (2006) Resistance to body fat gain in 'double-muscled' mice fed a high-fat diet. Int J Obes (Lond) 30(5): 868-870.
28. Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, et al. (2005) Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146(8): 3547-3557.
29. Feldman BJ, Streeper RS, Farese RV, Jr., Yamamoto KR (2006) Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A 103(42): 15675-15680.
30. Kishioka Y, Thomas M, Wakamatsu J, Hattori A, Sharma M, et al. (2008) Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity. J Cell Physiol 215(3): 856-867.
31. Miura T, Kishioka Y, Wakamatsu J, Hattori A, Hennebry A, et al. (2006) Decorin binds myostatin and modulates its activity to muscle cells. Biochem Biophys Res Commun 340(2): 675-680.
32. Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, et al. (2007) Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem 282(35): 25852-25863.
33. Carey AL, Bruce CR, Sacchetti M, Anderson MJ, Olsen DB, et al. (2004) Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 47(6): 1029-1037.
34. Lazar MA (2005) How obesity causes diabetes: not a tall tale. Science 307(5708): 373-375.
35. Al-Khalili L, Bouzakri K, Glund S, Lonnqvist F, Koistinen HA, et al. (2006) Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 20(12): 3364-3375.
36. Bruce CR, Dyck DJ (2004) Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 287(4): E616-621.
37. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121): 860-867.
38. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116(7): 1793-1801.
39. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1): 175-184.
40. Horsley V, Jansen KM, Mills ST, Pavlath GK (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113(4): 483-494.
41. McInnes A, Rennick DM (1988) Interleukin 4 induces cultured monocytes/ macrophages to form giant multinucleated cells. J Exp Med 167(2): 598-611.
42. Oh IS, Thaler JP, Ogimoto K, Wisse BE, Morton GJ, et al. Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am J Physiol Endocrinol Metab 299(1): E47-53.
43. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12): 1796-1808.
44. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, et al. (2008) Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 103(5): 467-476.
45. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1): 4-12.
46. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, et al. (2002) Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87(5): 2084-2089.
47. Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83(3): 847-850.
48. Hotamisligil G, Shargill N, Spiegelman B (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87.
49. Berg RE, Crossley E, Murray S, Forman J (2003) Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med 198(10): 1583-1593.
50. Berg RE, Crossley E, Murray S, Forman J (2005) Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J Immunol 175(3): 1751-1757.
51. Thomas M, Langley B, Berry C, Sharma M, Kirk S, et al. (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275(51): 40235-40243.
52. Biga PR, Cain KD, Hardy RW, Schelling GT, Overturf K, et al. (2004) Growth hormone differentially regulates muscle myostatin1 and -2 and increases circulating cortisol in rainbow trout (Oncorhynchus mykiss). Gen Comp Endocrinol 138(1): 32-41.
53. Rodgers BD, Weber GM, Kelley KM, Levine MA (2003) Prolonged fasting and cortisol reduce myostatin mRNA levels in tilapia larvae; short-term fasting elevates. Am J Physiol Regul Integr Comp Physiol 284(5): R1277-1286.
54. Willoughby DS (2004) Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 36(4): 574-582.